Omni Partners’s Evolent Health EVH Stock Holding History

Omni Partners’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-66,666	Closed	-$820K	–	28
2017 Q4	$820K	Buy	+66,666	New	+$940K	0.14%	17

Other funds holding EVH

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Formula Growth Montreal, Quebec, Canada $284M AUM 54.56% 1-Year Est. Return

Omni Partners's EVH Position: Q1 2018 in Review

Omni Partners sold out of Evolent Health (EVH) in Q1 2018, closing a stake of 66,666 shares — an estimated $820K sold.

Omni Partners first reported a position in EVH in Q4 2017 and held it in 1 quarter. The position peaked at $820K in Q4 2017. 152 funds tracked by Wall St. Rank hold EVH as of Q1 2018.

Omni Partners reported no remaining Evolent Health position as of Q1 2018 after selling out during the quarter.
Omni Partners sold 66,666 Evolent Health shares in Q1 2018, an estimated $820K.
Omni Partners first reported a position in Evolent Health in Q4 2017 and held it in 1 quarter.
Omni Partners's Evolent Health position peaked at $820K in Q4 2017.
152 funds tracked by Wall St. Rank held Evolent Health as of Q1 2018.

Based on Omni Partners's 13F filing for Q1 2018, filed 11 May 2018.